A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 2, Phase 3
- Study design
- RANDOMIZED · PARALLEL · SUPPORTIVE CARE · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 40
- Population
- ALL · 30 Years to 70 Years
- Duration
- 2024-09-27 to 2025-02-28
- Intervention
- CE Ferulic; Sham Comparator; 1927nm (Clear and Brilliant Perméa®)
- Comparator
- Group A
- Outcomes measured
- Global Fine Lines — Screening, Baseline, Day 28, Day 56, Day 84; Overall Hyperpigmentation/ Discoloration — Screening, Baseline, Day 28, Day 56, Day 84; Skin Tone Evenness — Screening, Baseline, Day 28, Day 56, Day 84; Skin Elasticity — Screening, Baseline, Day 28, Day 56, Day 84; Skin Firmness — Screening, Baseline, Day 28, Day 56, Day 84; Skin Radiance/ Brightness — Screening, Baseline, Day 28, Day 56, Day 84; Skin Texture Smoothness — Screening, Baseline, Day 28, Day 56, Day 84; Global Wrinkles — Screening, Baseline, Day 28, Day 56, Day 84; Tolerability Assessment — Baseline, Day 28; Dermatology Quality of Life Index (Page 1) — Screening, Baseline, Day 28, Day 56, Day 84; Dermatology Quality of Life Index (Page 2) — Screening, Baseline, Day 28, Day 56, Day 84; Subject Self-Assessment Questionnaire (Page 1) — Screening, Baseline, Day 28, Day 56, Day 84; Subject Self-Assessment Questionnaire (Page 2) — Screening, Baseline, Day 28, Day 56, Day 84; Subject Self-Assessment Questionnaire (Page 3) — Screening, Baseline, Day 28, Day 56, Day 84
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Skin ageing · 100%Title contains controlled term: photoaging. Source terminology contains: photoaging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.